Results 121 to 130 of about 78,579 (196)
Improved Cardiac Structure and Ventricular-Arterial Coupling After Baroreflex Activation Therapy. [PDF]
JACC Case RepAlhasan F +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Separation Science Plus
This study involved the development and validation of a precise and reliable RP‐HPLC method for the concurrent quantification of empagliflozin and metoprolol succinate in formulations, adhering to the Q2(R1) guidelines established by the International ...
Heena Ninama, Shailesh K. Koradia
exaly +2 more sources
This study involved the development and validation of a precise and reliable RP‐HPLC method for the concurrent quantification of empagliflozin and metoprolol succinate in formulations, adhering to the Q2(R1) guidelines established by the International ...
Heena Ninama, Shailesh K. Koradia
exaly +2 more sources
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2023
The aim of this study is to develop and validate two simple spectrophotometric methods for simultaneous determination of metoprolol succinate (MET) and olmesartan medoxomil (OLM) in tablet form. Method (I) was area under the curve (AUC) method.
Sherin F Hammad, Amira Kamal
exaly +2 more sources
The aim of this study is to develop and validate two simple spectrophotometric methods for simultaneous determination of metoprolol succinate (MET) and olmesartan medoxomil (OLM) in tablet form. Method (I) was area under the curve (AUC) method.
Sherin F Hammad, Amira Kamal
exaly +2 more sources
Marked hypertriglyceridemia in a woman receiving metoprolol succinate
Journal of Clinical Lipidology, 2014β-blockers are commonly used therapies after acute myocardial infarction and in the management of congestive heart failure and hypertension. We report a case of a middle-aged woman with a history of mild hypertension who was placed on metoprolol succinate.
, Yeunjung Kim
exaly +3 more sources
Drug Development and Industrial Pharmacy
Background Empagliflozin a sodium-glucose co-transporter 2 inhibitor, and Metoprolol succinate, a cardioselective β1-blocker, are co-formulated in a novel bilayer tablet currently under clinical evaluation.
Heena Ninama, Shaileshkumar K. Koradia
semanticscholar +1 more source
Background Empagliflozin a sodium-glucose co-transporter 2 inhibitor, and Metoprolol succinate, a cardioselective β1-blocker, are co-formulated in a novel bilayer tablet currently under clinical evaluation.
Heena Ninama, Shaileshkumar K. Koradia
semanticscholar +1 more source
Indian drugs
Myocardial infarction affects millions of people worldwide, necessitating effective management strategies. The Drugs Controller General of India approved a combination of dapagliflozin propanediol monohydrate and metoprolol succinate for the management ...
S. Surendran +5 more
semanticscholar +1 more source
Myocardial infarction affects millions of people worldwide, necessitating effective management strategies. The Drugs Controller General of India approved a combination of dapagliflozin propanediol monohydrate and metoprolol succinate for the management ...
S. Surendran +5 more
semanticscholar +1 more source
Effect of naringenin on the pharmacokinetics of metoprolol succinate in rats
Xenobiotica, 2021The aim of the present study was to investigate the effect of naringenin (4,5,7-trihydroxy flavonone) on the pharmacokinetics of metoprolol, a substrate of Cytochrome P-450 3A4 (CYP3A4), CYP2C9, and CYP2D6 in rats.Male Wistar rats were treated orally with metoprolol (30 mg/kg) alone and in combination with naringenin (25, 50, and 100 mg/kg) once daily ...
Ravindra Babu, Pingili +5 more
openaire +2 more sources